152 related articles for article (PubMed ID: 36939057)
1. Cribriform morphology is associated with higher risk of biochemical recurrence after radical prostatectomy in patients with Grade Group 5 prostate cancer.
Oufattole J; Dey T; D'Amico AV; van Leenders GJLH; Acosta AM
Histopathology; 2023 Jun; 82(7):1089-1097. PubMed ID: 36939057
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease.
Ma C; Downes M; Jain R; Ientilucci M; Fleshner N; Perlis N; van der Kwast T
Prostate; 2022 Feb; 82(3):345-351. PubMed ID: 34878188
[TBL] [Abstract][Full Text] [Related]
3. Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis.
Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Helleman J; Roobol MJ; van Leenders GJLH
Mod Pathol; 2019 Jan; 32(1):139-146. PubMed ID: 30349027
[TBL] [Abstract][Full Text] [Related]
4. Comedonecrosis Gleason pattern 5 is associated with worse clinical outcome in operated prostate cancer patients.
Hansum T; Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Osanto S; Pelger RCM; van Wezel T; van der Poel H; Bekers E; Helleman J; Remmers S; van Leenders GJLH
Mod Pathol; 2021 Nov; 34(11):2064-2070. PubMed ID: 34175896
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of tumor morphologies and association with biochemical recurrence after radical prostatectomy in grade group 5 prostate cancer.
Flood TA; Schieda N; Sim J; Breau RH; Morash C; Belanger EC; Robertson SJ
Virchows Arch; 2018 Feb; 472(2):205-212. PubMed ID: 28975495
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome comparison of Grade Group 1 and Grade Group 2 prostate cancer with and without cribriform architecture at the time of radical prostatectomy.
Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Roobol MJ; Helleman J; van Leenders GJLH
Histopathology; 2020 Apr; 76(5):755-762. PubMed ID: 31944367
[TBL] [Abstract][Full Text] [Related]
7. Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients.
Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Osanto S; Pelger RCM; van Wezel T; van der Poel H; Bekers E; Helleman J; Roobol MJ; van Leenders GJLH
Mod Pathol; 2021 Jan; 34(1):184-193. PubMed ID: 32686748
[TBL] [Abstract][Full Text] [Related]
8. Cribriform Morphology in Gleason Score 3+4 Moderate-Risk Prostate Cancer: Is it Risk Factor for Biochemical Recurrence?
Yahşi S; Ceylan C; Kizilkan Y; Şenel S; Ceviz K
Arch Esp Urol; 2022 May; 75(4):325-329. PubMed ID: 35818912
[TBL] [Abstract][Full Text] [Related]
9. Expansile cribriform Gleason pattern 4 has histopathologic and molecular features of aggressiveness and greater risk of biochemical failure compared to glomerulation Gleason pattern 4.
Greenland NY; Cowan JE; Zhang L; Carroll PR; Chan E; Stohr BA; Simko JP
Prostate; 2020 May; 80(8):653-659. PubMed ID: 32220141
[TBL] [Abstract][Full Text] [Related]
10. Prostatic Ductal Adenocarcinoma Controlled for Tumor Grade, Stage, and Margin Status Does Not Independently Influence the Likelihood of Biochemical Recurrence in Localized Prostate Cancer After Radical Prostatectomy.
Kryvenko ON; Iakymenko OA; De Lima Guido LP; Bhattu AS; Merhe A; Mouzannar A; Briski LM; Oymagil I; Lugo I; Nemov I; Ritch CR; Kava BR; Punnen S; Jorda M; Parekh DJ; Gonzalgo ML
Arch Pathol Lab Med; 2022 Aug; 146(8):1012-1017. PubMed ID: 34739539
[TBL] [Abstract][Full Text] [Related]
11. Prostate Carcinoma Grade and Length But Not Cribriform Architecture at Positive Surgical Margins Are Predictive for Biochemical Recurrence After Radical Prostatectomy.
Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Helleman J; Roobol MJ; van Leenders GJLH
Am J Surg Pathol; 2020 Feb; 44(2):191-197. PubMed ID: 31592799
[TBL] [Abstract][Full Text] [Related]
12. Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4=7 prostate cancer.
Kweldam CF; Kümmerlin IP; Nieboer D; Steyerberg EW; Bangma CH; Incrocci L; van der Kwast TH; Roobol MJ; van Leenders GJ
Mod Pathol; 2017 Aug; 30(8):1126-1132. PubMed ID: 28530220
[TBL] [Abstract][Full Text] [Related]
13. Improved Prostate Cancer Biopsy Grading by Incorporation of Invasive Cribriform and Intraductal Carcinoma in the 2014 Grade Groups.
van Leenders GJLH; Kweldam CF; Hollemans E; Kümmerlin IP; Nieboer D; Verhoef EI; Remmers S; Incrocci L; Bangma CH; van der Kwast TH; Roobol MJ
Eur Urol; 2020 Feb; 77(2):191-198. PubMed ID: 31439369
[TBL] [Abstract][Full Text] [Related]
14. Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer.
Kweldam CF; Wildhagen MF; Steyerberg EW; Bangma CH; van der Kwast TH; van Leenders GJ
Mod Pathol; 2015 Mar; 28(3):457-64. PubMed ID: 25189638
[TBL] [Abstract][Full Text] [Related]
15. Cribriform architecture outperforms Gleason pattern 4 percentage and tertiary Gleason pattern 5 in predicting the outcome of Grade Group 2 prostate cancer patients.
Seyrek N; Hollemans E; Osanto S; Pelger RCM; van der Poel HG; Bekers E; Bangma CH; Rietbergen J; Roobol MJ; Schoots IG; van Leenders GJLH
Histopathology; 2022 Feb; 80(3):558-565. PubMed ID: 34706119
[TBL] [Abstract][Full Text] [Related]
16. Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies.
Shah RB; Magi-Galluzzi C; Han B; Zhou M
Am J Surg Pathol; 2010 Apr; 34(4):470-7. PubMed ID: 20182345
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Accuracy of Prostate Biopsy for Detecting Cribriform Gleason Pattern 4 Carcinoma and Intraductal Carcinoma in Paired Radical Prostatectomy Specimens: Implications for Active Surveillance.
Ericson KJ; Wu SS; Lundy SD; Thomas LJ; Klein EA; McKenney JK
J Urol; 2020 Feb; 203(2):311-319. PubMed ID: 31483693
[TBL] [Abstract][Full Text] [Related]
18. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer with comedonecrosis is frequently, but not exclusively, intraductal carcinoma: a need for reappraisal of grading criteria.
Madan R; Deebajah M; Alanee S; Gupta NS; Carskadon S; Palanisamy N; Williamson SR
Histopathology; 2019 Jun; 74(7):1081-1087. PubMed ID: 30720899
[TBL] [Abstract][Full Text] [Related]
20. Large cribriform glands (> 0.25 mm diameter) as a predictor of adverse pathology in men with Grade Group 2 prostate cancer.
Greenland NY; Cowan JE; Stohr BA; Simko JP; Carroll PR; Chan E
Histopathology; 2024 Mar; 84(4):614-623. PubMed ID: 38012532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
